| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
| |
| |
December 19, 2011 |
|
|
| |
|
|
| |
|
|
|
CfPA - The Center for Professional Advancement, Burlingame, CA
June 12-14, 2012
Who Should Attend
This overview course is intended for those having specific responsibilities in the areas of sterile drug product science and technology. It will be of particular value to those in:
• Research
• Development
• Production
• Quality Assurance and Control
Those who wish to broaden their appreciation of these technologies and review the latest developments, as well as managers who have responsibility for a broader base of activities will find the course of interest. Description
This comprehensive course provides an appreciation and general understanding of the overall contemporary state of science and technology associated with the design, development and manufacturing of sterile drug dosage forms. Emphasis will be oriented toward formulation development and product manufacture of quality sterile dosage forms that meet or exceed expected good manufacturing practice requirements.
|
|
|
|
|
|
|
|
Organized by:
|
|
CfPA - The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
Dr. Michael J. Akers; Senior Director of Pharmaceutical R&D, Baxter BioPharma Solutions
Dr. Michael J. Akers has taught sterile product courses for 35 years. He has 40 years of experience in the development and manufacture of sterile dosage forms including solutions, suspensions, ophthalmics and freeze dried products. He has contributed to the filing of eleven new drug applications including Humulin® Cartridges and Gemzar®. Currently Dr. Akers is Senior Director of Pharmaceutical Research and Development for Baxter BioPharma Solutions in Bloomington, IN. Previously, he served as an independent consultant for the parenteral industry with over 60 clients. His background includes significant experiences at Searle (now Pfizer), Alcon, and Eli Lilly. He also was professor of pharmaceutics at the University of Tennessee College of Pharmacy and currently is adjunct professor at six schools of pharmacy. He has authored, co-authored, or edited 4 books and 20 book chapters including the chapter on Parenteral Products that will appear in the new 22nd edition of Remington's The Science and Practice of Pharmacy, 2012.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
sberg@cfpa.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|